AG˹ٷ

STOCK TITAN

Quanex Building Products Announces Third Quarter 2025 Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Quanex Building Products (NYSE:NX) reported its Q3 2025 results with net sales of $495.3 million, representing a 76.7% increase compared to the same period in 2024, primarily driven by the Tyman acquisition. The company reported a net loss of $276.0 million, mainly due to a $302.3 million non-cash goodwill impairment related to business re-segmentation.

Key financial highlights include gross margin improvement to 27.9% from 25.3% year-over-year, and Adjusted EBITDA of $70.3 million. The company strengthened its balance sheet by repaying $51.25 million in debt during Q3, reducing its leverage ratio to 2.6x. Quanex updated its FY2025 guidance, projecting net sales of approximately $1.82 billion and Adjusted EBITDA of $235 million.

Quanex Building Products (NYSE:NX) ha comunicato i risultati del 3° trimestre 2025 con ricavi netti di $495,3 milioni, in aumento del 76,7% rispetto allo stesso periodo del 2024, trainati principalmente dall’acquisizione di Tyman. La società ha registrato una perdita netta di $276,0 milioni, dovuta in larga parte a una svalutazione non monetaria di avviamento di $302,3 milioni legata alla riorganizzazione del business.

Tra i principali indicatori finanziari si segnala un miglioramento del margine lordo al 27,9% rispetto al 25,3% dell’anno precedente e un Adjusted EBITDA di $70,3 milioni. L’azienda ha rafforzato il proprio bilancio rimborsando $51,25 milioni di debito nel trimestre, portando il rapporto di leva a 2,6x. Quanex ha aggiornato le stime per il FY2025, prevedendo ricavi netti di circa $1,82 miliardi e un Adjusted EBITDA di $235 milioni.

Quanex Building Products (NYSE:NX) informó sus resultados del 3T 2025 con ventas netas de $495.3 millones, un incremento del 76.7% respecto al mismo periodo de 2024, impulsado principalmente por la adquisición de Tyman. La compañía registró una pérdida neta de $276.0 millones, atribuida en gran parte a un deterioro no monetario del goodwill por $302.3 millones relacionado con la resegmentación del negocio.

Entre los indicadores financieros clave destaca la mejora del margen bruto al 27.9% desde 25.3% interanual, y un Adjusted EBITDA de $70.3 millones. La empresa fortaleció su balance al reembolsar $51.25 millones de deuda durante el trimestre, reduciendo su ratio de apalancamiento a 2.6x. Quanex actualizó su guía para FY2025, proyectando ventas netas de aproximadamente $1.82 mil millones y un Adjusted EBITDA de $235 millones.

Quanex Building Products (NYSE:NX)2025 회계연도 3분기 실적� 발표하며 순매� $495.3백만� 기록했다� 밝혔습니�. 이 2024� 동기 대� 76.7% 증가� 수치�, 주로 Tyman 인수� 기인합니�. 회사� 순손� $276.0백만� 보고했으�, 이 사업 재분할과 관련된 무형� 영업� 손상차손 $302.3백만� 따른 비현금성 손실� 주된 원인입니�.

주요 재무 포인트로� 매출총이익률� 전년 대� 25.3%에서 27.9%� 개선되었�, 조정 EBITDA $70.3백만� 기록했습니다. 회사� 3분기 동안 $51.25백만� 부채를 상환� 재무구조� 강화했으�, 레버리지 비율� 2.6배로 낮췄습니�. Quanex� FY2025 전망� 업데이트하여 순매� � $1.82십억조정 EBITDA $235백만� 예상하고 있습니다.

Quanex Building Products (NYSE:NX) a publié ses résultats du 3e trimestre 2025 avec chiffre d’affaires net de 495,3 M$, soit une hausse de 76,7% par rapport à la même période en 2024, principalement portée par l’acquisition de Tyman. La société a enregistré une perte nette de 276,0 M$, essentiellement liée à une dépréciation non monétaire du goodwill de 302,3 M$ liée à une re-segmentation de l’activité.

Parmi les points financiers clés figurent une amélioration de la marge brute à 27,9% contre 25,3% sur un an, et un EBITDA ajusté de 70,3 M$. La société a renforcé son bilan en remboursant 51,25 M$ de dette au cours du trimestre, réduisant son ratio d’endettement à 2,6x. Quanex a mis à jour ses prévisions FY2025, projetant un chiffre d’affaires net d’environ 1,82 Md$ et un EBITDA ajusté de 235 M$.

Quanex Building Products (NYSE:NX) meldete seine Ergebnisse für das 3. Quartal 2025 mit Nettoerlösen von $495,3 Mio., was einem Anstieg von 76,7% gegenüber dem Vorjahreszeitraum entspricht und vor allem durch die Übernahme von Tyman getrieben wurde. Das Unternehmen verzeichnete einen Nettoverlust von $276,0 Mio., der hauptsächlich auf eine nicht-liquiditätswirksame Firmenwertabschreibung von $302,3 Mio. im Zusammenhang mit einer Neustrukturierung des Geschäftssegments zurückzuführen ist.

Wesentliche finanzielle Kennzahlen umfassen eine Verbesserung der Bruttomarge auf 27,9% gegenüber 25,3% im Vorjahr sowie ein bereinigtes EBITDA von $70,3 Mio.. Das Unternehmen stärkte seine Bilanz durch die Rückzahlung von $51,25 Mio. an Schulden im Quartal und senkte damit die Verschuldungskennzahl auf 2,6x. Quanex hat seine FY2025-Prognose aktualisiert und erwartet Nettoerlöse von rund $1,82 Mrd. und ein bereinigtes EBITDA von $235 Mio.

Positive
  • Significant net sales growth of 76.7% year-over-year to $495.3 million
  • Gross margin improved to 27.9% from 25.3% year-over-year
  • Strong debt reduction with $51.25 million repaid in Q3
  • Increased cost synergy target to $45 million from initial $30 million projection
  • Healthy liquidity position of $337.7 million as of July 31, 2025
Negative
  • Reported net loss of $276.0 million due to goodwill impairment
  • Operational challenges in legacy Tyman window and door hardware business in Mexico
  • Lower than expected procurement-related cost synergies
  • Adjusted EBITDA margin declined to 14.2% from 15.0% year-over-year
  • Free cash flow decreased to $35.6 million from $59.9 million for the nine-month period

Insights

Quanex reported mixed Q3 results with strong sales growth but took a $302M goodwill impairment charge; debt reduction remains a bright spot.

Quanex's Q3 2025 results present a complex financial picture dominated by the ongoing integration of their Tyman acquisition. The 76.7% year-over-year revenue increase to $495.3 million looks impressive but primarily reflects the Tyman contribution, with organic growth at just 1.4%. The headline $276 million net loss stems from a $302.3 million non-cash goodwill impairment related to business re-segmentation, rather than operational failures.

The company's fundamentals show some strength amid challenges. Gross margin expanded to 27.9% from 25.3% last year, while Adjusted EBITDA increased to $70.3 million from $42.0 million. However, Adjusted EBITDA margin contracted to 14.2% from 15.0%, indicating integration inefficiencies or cost pressures.

Quanex's balance sheet improvement stands out as the quarter's most positive development. The company repaid $51.25 million in debt, reducing its net debt to LTM Adjusted EBITDA ratio to 2.6x with total debt at $733.7 million. With $66.3 million cash on hand and $337.7 million in total liquidity, Quanex has financial flexibility despite its debt load.

Management's reduced guidance—now projecting $1.82 billion in annual sales and $235 million in Adjusted EBITDA—reflects operational challenges at Tyman's Mexico facility, delayed procurement synergies, and weakening demand trends. While the company reaffirmed its $45 million cost synergy target from the Tyman acquisition, the adjusted timeline suggests integration complexities.

The combination of temporary operational issues, challenging macroeconomic conditions, and a significant non-cash accounting charge creates a noisy quarter that masks the company's underlying trajectory. Investors should monitor whether the promised synergies materialize and if operational issues in Mexico are truly transitory.

New Segment Reporting Implemented
Balance Sheet Further Strengthened with $51.25 Million of Debt Repaid in 3Q25
Cost Synergy Target Reaffirmed
Full Year Guidance Updated

HOUSTON, Sept. 04, 2025 (GLOBE NEWSWIRE) -- (NYSE:NX) (“Quanex� or the “Company�) today announced its results for the three months ended July 31, 2025.

The Company reported the following selected financial results:

Three Months Ended July 31,Nine Months Ended July 31,
($ in millions, except per share data)2025202420252024
Net Sales$495.3$280.3$1,347.8$785.7
Gross Margin$138.0$70.9$361.7$188.6
Gross Margin %27.9%25.3%26.8%24.0%
Net (loss) income($276.0)$25.4($270.4)$47.0
Diluted EPSrticles/eps-explained-simple-example" title="Read: EPS Explained with a Simple Example: The Most Important Stock Metric" class="article-link" rel="noopener">Diluted EPS($6.04)$0.77($5.83)$1.42
Adjusted Net Income$31.6$26.9$68.4$60.7
Adjusted Diluted EPSrticles/eps-explained-simple-example" title="Read: EPS Explained with a Simple Example: The Most Important Stock Metric" class="article-link" rel="noopener">Diluted EPS$0.69$0.81$1.47$1.84
Adjusted EBITDA$70.3$42.0$172.0$101.3
Adjusted EBITDA Marginicles/ebitda-vs-operating-income" title="Read: EBITDA vs Operating Income: Key Differences Every Investor Should Know" class="article-link" rel="noopener">EBITDA Margin %14.2%15.0%12.8%12.9%
Cash Provided by Operating Activities$60.7$46.4$76.6$83.3
Free Cash Flow$46.2$40.1$35.6$59.9

(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)

George Wilson, Chairman, President and Chief Executive Officer, stated, “A significant amount of work had to be done to re-segment the business, so we are pleased that the work is now complete, and we are operating and reporting in our new segments. We are encouraged by the overall resilience of the business in the current environment, demonstrated by our strong cash flow, which enabled us to repay over $51 million in bank debt in the third quarter of 2025. Our balance sheet is healthy, and our liquidity improved meaningfully during the quarter. We continue to make substantial progress on the integration of the Tyman business. After identifying additional target synergies and adjusting for lower expected volumes and pushing out the timing of when we expect to realize procurement savings, we still believe there is a path to realizing approximately $45 million in cost synergies over time, which is above our initial projection of $30 million. Although macroeconomic uncertainty and low consumer confidence, as well as operational issues related to the legacy Tyman window and door hardware business in Mexico that are ongoing but temporary in nature, posed challenges for us in our third quarter, we remain optimistic about our prospects for profitable growth and value creation.

Looking ahead, we believe Quanex is well positioned due to our solid, flexible financial foundation and advantaged strategic positioning. Despite the macroeconomic uncertainty, our near-term priorities remain unchanged, which include staying focused on the Tyman integration, capturing synergies, generating cash flow to pay down debt and opportunistically repurchasing our stock. As macroeconomic uncertainty subsides and consumer confidence improves, our team is well positioned to capitalize on pent-up demand.�

Third Quarter Results Summary

Quanex generated net sales of $495.3 million during the three months ended July 31, 2025, which represents an increase of 76.7% compared to $280.3 million for the same period of 2024. The increase reflects the contribution from the Tyman acquisition that closed on August 1, 2024. Excluding the contribution from Tyman, net sales would have increased by 1.4% for the third quarter of 2025, mainly due to increased pricing and tariff passthroughs, offset by lower volumes. Inclusive of contributions from the Tyman acquisition, the Company reported increases in net sales of 201.0%, 29.6% and 40.7% for the third quarter of 2025 in its Hardware Solutions, Extruded Solutions and Custom Solutions segments, respectively. (See Sales Analysis table for additional information)

On a consolidated basis, the decrease in reported earnings for the three months ended July 31, 2025, was primarily the result of a $302.3 million non-cash goodwill impairment related to the re-segmentation of the business. The re-segmentation occurred at a point in time when consumer confidence is low, and equity values for building products companies are depressed. The non-cash goodwill impairment is not related to any performance indicators or revisions to long-term expectations. In addition, ongoing macroeconomic uncertainty, low consumer confidence and operational challenges related to the legacy Tyman window and door hardware business in Mexico impacted results more than expected during the third quarter of 2025. The seasonal uptick Quanex started to see in the second quarter of 2025 didn’t continue to materialize to the degree the Company anticipated, and procurement related cost synergies were lower than expected.

The increase in adjusted earnings during the third quarter of 2025, compared to the same period of 2024, was mostly due to the contribution from the Tyman acquisition combined with the realization of related cost synergies.

Balance Sheet & Liquidity Update

As of July 31, 2025, the Company had total debt of $733.7 million and Quanex’s leverage ratio of Net Debt to LTM Adjusted EBITDA decreased to 2.6x. As of July 31, 2025, the Company reported a LTM Net Loss of $284.3 million, mainly due to the non-cash goodwill impairment and LTM Adjusted EBITDA was $251.8 million (See Non-GAAP Terminology Definitions and Disclaimers section, Net Debt Reconciliation table and Last Twelve Months Adjusted EBITDA Reconciliation table for additional information)

The leverage ratio for Quanex’s quarterly debt covenant compliance (“Debt Covenant Leverage Ratio�) for its lenders was 2.4x as of July 31, 2025. The Debt Covenant Leverage Ratio calculation is defined in the Company’s Amendment No. 1 to its Second Amended and Restated Credit Agreement (“Credit Agreement�), which was filed with the SEC on June 12, 2024. In general, the main difference is that the Debt Covenant Leverage Ratio excludes real-estate leases that are considered “finance� leases under U.S. GAAP and is calculated on a proforma basis to include Adjusted EBITDA from the Tyman acquisition, $30 million of EBITDA for the synergy target related to the acquisition, less realized synergies, and only cash from domestic subsidiaries. Note that per the terms of the Credit Agreement, the quarterly Debt Covenant Leverage Ratio must be less than 3.75x through the fourth quarter of 2025 and less than 3.25x starting in the first fiscal quarter of 2026. The Debt Covenant Leverage Ratio would be 2.3x if calculated using the full $66.3 million cash and cash equivalents balance as of July 31, 2025, and adjusting for the $2.1 million in cash used to repurchase stock during the quarter.

Quanex’s liquidity improved to $337.7 million as of July 31, 2025, consisting of $66.3 million in cash on hand plus availability under its Senior Secured Revolving Credit Facility due 2029, less letters of credit outstanding.

Share Repurchases

Quanex’s Board authorized a $75 million share repurchase program in December of 2021. Repurchases under this program will be made in open market transactions or privately negotiated transactions, subject to market conditions, applicable legal requirements, and other relevant factors. The Company repurchased 100,000 shares of common stock for approximately $2.1 million at an average price of $20.54 per share during the three months ended July 31, 2025. As of July 31, 2025, approximately $33.6 million remained under the existing share repurchase authorization.

Outlook

Quanex is updating its guidance for fiscal 2025 based on year-to-date results, recent demand trends, an updated cost synergy realization tracking and timing model, conversations with its customers, and a realistic timeline to address operational issues in the window and door hardware business in Mexico. On a consolidated basis for fiscal 2025, the Company now estimates that it will generate net sales of approximately $1.82 billion, which Quanex expects will yield Adjusted EBITDA* of approximately $235 million.

Mr. Wilson commented, “We have a strong team with a proven track record and a breadth of products that are unmatched in the industry, which gives us confidence in our ability to execute on our long-term operational and financial objectives.�

*When Quanex provides expectations for Adjusted EBITDA on a forward-looking basis, a reconciliation of the differences between the non-GAAP expectations and corresponding GAAP measures is generally not available without unreasonable effort. Certain items required for such a reconciliation are outside of the Company’s control and/or cannot be reasonably predicted or estimated, such as the provision for income taxes related to net income.

Conference Call and Webcast Information

The Company has also scheduled a conference call for Friday, September 5, 2025 at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex’s website at in the Investors section under Presentations & Events.

Participants can pre-register for the conference call using the following link:

Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company’s website at in the Investors section under Presentations & Events.

About Quanex

Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently collaborates and partners with leading OEMs to provide innovative solutions in the window, door, solar, refrigeration, custom mixing, building access and cabinetry markets. Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.

Non-GAAP Terminology Definitions and Disclaimers

Adjusted Net Income (defined as net income further adjusted to exclude amortization of step-up for purchase price adjustments on inventory, asset impairment charges, transaction, advisory fees and reorganization costs, restructuring charges related to severance and disposal of software, amortization expense related to intangible assets, pension settlement refund and other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflects operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net), Adjusted EBITDA and LTM Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making. Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex’s leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company’s credit agreement.

Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making. Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company’s residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company’s financial and cash management performance.

Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company’s financial performance when comparing results to other investment opportunities. The presented non-GAAP measures may not be the same as those used by other companies. Quanex does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.

Forward Looking Statements

Statements that use the words “estimated,� “expect,� “could,� “should,� “believe,� “will,� “might,� or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: impacts from public health issues (including pandemics) on the economy and the demand for Quanex’s products, timing estimates or any other expectations related to the acquisition of Tyman, the Company’s future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to Quanex’s industry, and the Company’s future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from this release. For a complete discussion of factors that may affect Quanex’s future performance, please refer to the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2024, and the Company’s Quarterly Reports on Form 10-Q under the sections entitled “Cautionary Note Regarding Forward-Looking Statements� and “Risk Factors�. Any forward-looking statements in this press release are made as of the date hereof, and Quanex undertakes no obligation to update or revise any forward-looking statements to reflect new information or events.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
(Unaudited)
Three Months Ended July 31,Nine Months Ended July 31,
2025202420252024
Net sales$495,273$280,345$1,347,795$785,701
Cost of sales357,305209,441986,129597,127
Selling, general and administrative71,27036,509208,253103,579
Restructuring charges1,367-10,207-
Depreciation and amortization33,88210,95377,81432,999
Asset impairment charges302,284-302,284-
Operating (loss) income(270,835)23,442(236,892)51,996
Interest expense(14,218)(878)(42,344)(2,896)
Other, net8559,4741,92510,520
(Loss) income before income taxes(284,198)32,038(277,311)59,620
Income tax benefit (expense)8,191(6,688)6,934(12,644)
Net (loss) income$(276,007)$25,350$(270,377)$46,976
(Loss) earnings per common share, basic$(6.04)$0.77$(5.83)$1.43
(Loss) earnings per common share, diluted$(6.04)$0.77$(5.83)$1.42
Weighted average common shares outstanding:
Basic45,69132,87646,39532,857
Diluted45,69133,10646,39533,087
Cash dividends per share$0.08$0.08$0.24$0.24


QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)
July 31, 2025October 31, 2024
ASSETS
Current assets:
Cash and cash equivalents$66,272$97,744
Restricted Cash1,6545,251
Accounts receivable, net201,837197,689
Inventories272,222275,550
Income taxes receivable-5,937
Prepaid and other current assets41,33929,097
Total current assets583,324611,268
Property, plant and equipment, net405,510402,466
Operating lease right-of-use assets147,829126,715
Deferred tax assets3,6543,845
Goodwill271,459574,711
Intangible assets, net558,768597,909
Other assets2,1332,874
Total assets$1,972,677$2,319,788
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable$126,486$124,404
Accrued liabilities95,378103,623
Income taxes payable1,2736,620
Current maturities of long-term debt26,31325,745
Current operating lease liabilities15,24312,475
Total current liabilities264,693272,867
Long-term debt695,605737,198
Noncurrent operating lease liabilities138,246117,560
Deferred income taxes143,576162,304
Other liabilities13,16619,113
Total liabilities1,255,2861,309,042
Stockholders� equity:
Common stock512513
Additional paid-in-capital699,106701,008
Retained earnings148,795430,405
Accumulated other comprehensive loss(30,501)(46,428)
Treasury stock at cost(100,521)(74,752)
Total stockholders� equity717,3911,010,746
Total liabilities and stockholders' equity$1,972,677$2,319,788


QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(In thousands)
(Unaudited)
Nine Months Ended July 31,
20252024
Operating activities:
Net (loss) income$(270,377)$46,976
Adjustments to reconcile net (loss) income to cash provided by operating activities:
Depreciation and amortization77,81432,999
Stock-based compensation2,7622,159
Deferred income tax(26,440)(2,321)
Asset impairment charge302,284-
Gain on deal contingent foreign exchange forward currency contract-(9,200)
Other, net9,203886
Changes in assets and liabilities:
(Increase) decrease in accounts receivable(1,727)11,114
Decrease (increase) in inventory5,261(183)
(Increase) decrease in other current assets(7,228)1,646
Increase (decrease) in accounts payable144(9,634)
(Decrease) increase in accrued liabilities(9,725)948
(Decrease) increase in income taxes payable(21)6,659
(Decrease) increase in other long-term liabilities(5,395)707
Other, net88577
Cash provided by operating activities76,64383,333
Investing activities:
Capital expenditures(40,996)(23,435)
Proceeds from disposition of capital assets361115
Cash used for investing activities(40,635)(23,320)
Financing activities:
Borrowings under credit facilities170,000-
Repayments of credit facility borrowings(213,750)(15,000)
Repayments of other long-term debt(1,962)(1,893)
Common stock dividends paid(11,233)(7,943)
Issuance of common stock214573
Payroll tax paid to settle shares forfeited upon vesting of stock(1,400)(1,193)
Purchase of treasury stock(29,248)-
Cash used for financing activities(87,379)(25,456)
Effect of exchange rate changes on cash and cash equivalents16,302935
(Decrease) increase in cash, cash equivalents and restricted cash(35,069)35,492
Cash, cash equivalents and restricted cash at beginning of period102,99558,474
Cash, cash equivalents and restricted cash at end of period$67,926$93,966


QUANEX BUILDING PRODUCTS CORPORATION
FREE CASH FLOW AND NET DEBT RECONCILIATION
(In thousands)
(Unaudited)
The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures.
Three Months Ended July 31,Nine Months Ended July 31,
2025202420252024
Cash provided by operating activities$60,656$46,38876,643$83,333
Capital expenditures(14,452)(6,252)(40,996)(23,435)
Free Cash Flow$46,204$40,136$35,647$59,898
The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash.
As of July 31,
20252024
Term loan facility$475,000$0
Revolving credit facility197,500-
Finance lease obligations(1)61,19455,007
Total debt(2)733,69455,007
Less: Cash and cash equivalents66,27293,966
Net Debt$667,422($38,959)
(1) Includes $58.9 million and $50.7 million in real estate lease liabilities considered finance leases under U.S. GAAP as of July 31, 2025 and 2024, respectively.
(2) Excludes outstanding letters of credit.


QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION
(In thousands, except per share data)
(Unaudited)
Reconciliation of Last Twelve Months Adjusted EBITDAThree Months Ended
July 31, 2025
Three Months Ended
April 30, 2025
Three Months Ended
January 31, 2025
Three Months Ended
October 31, 2024
Total
ReconciliationReconciliationReconciliationReconciliationReconciliation
Net (loss) income as reported$(276,007)$20,515$(14,885)$(13,917)$(284,294)
Income tax (benefit) expense(8,191)6,307(5,050)(3,621)(10,555)
Other, net(855)159(1,229)2,671746
Interest expense14,21813,94014,18617,69760,041
Depreciation and amortization33,88219,19224,74027,329105,143
Asset impairment charges302,284---302,284
EBITDA65,33160,11317,76230,159173,365
Cost of sales(1)148--8871,035
Selling, general and administrative(1),(2),(3)3,44986412,87650,00467,193
Restructuring charges(4)1,3679367,904-10,207
Adjusted EBITDA$70,295$61,913$38,542$81,050$251,800
(1) Expense related to plant closure/relocation.
(2) Transaction, advisory fees, reorganization costs and product recall expenses.
(3) Amortization of step-up for purchase price adjustments on inventory.
(4) Restructuring charges related to severeance and disposal of software.


QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
(In thousands, except per share data)
(Unaudited)
Reconciliation of Adjusted Net Income and Adjusted EPSThree Months Ended July 31, 2025Three Months Ended July 31, 2024Nine Months Ended July 31, 2025Nine Months Ended July 31, 2024
Net
Income
Diluted
EPS
Net
Income
Diluted
EPS
Net
Income
Diluted
EPS
Net
Income
Diluted
EPS
Net (loss) income as reported$(276,007)$(6.04)$25,350$0.77$(270,377)$(5.83)$46,976$1.42
Net (loss) income reconciling items from below307,578$6.731,597$0.04338,756$7.3013,757$0.42
Adjusted net income and adjusted EPS$31,571$0.69$26,947$0.81$68,379$1.47$60,733$1.84
Reconciliation of Adjusted EBITDAThree Months Ended July 31, 2025Three Months Ended July 31, 2024Nine Months Ended July 31, 2025Nine Months Ended July 31, 2024
ReconciliationReconciliationReconciliationReconciliation
Net (loss) income as reported$(276,007)$25,350$(270,377)$46,976
Income tax (benefit) expense(8,191)6,688(6,934)12,644
Other, net(855)(9,474)(1,925)(10,520)
Interest expense14,21887842,3442,896
Depreciation and amortization33,88210,95377,81432,999
Asset impairment charges302,284-302,284-
EBITDA65,33134,395143,20684,995
EBITDA reconciling items from below4,9647,64028,76616,338
Adjusted EBITDA$70,295$42,035$171,972$101,333
Reconciling ItemsThree Months Ended July 31, 2025Three Months Ended July 31, 2024Nine Months Ended July 31, 2025Nine Months Ended July 31, 2024
Income StatementReconciling ItemsIncome StatementReconciling ItemsIncome StatementReconciling ItemsIncome StatementReconciling Items
Net sales$495,273$-$280,345$-$1,347,795$-$785,701$-
Cost of sales357,305(148)(1)209,441(1,507)(1)986,129(1,124)(1)597,127(2,138)(1)
Selling, general and administrative71,270(3,449)(1),(2)36,509(6,133)(1),(2)208,253(17,435)(1),(2),(3)103,579(14,200)(1),(2)
Restructuring charges1,367(1,367)(4)--10,207(10,207)(4)--
EBITDA65,3314,96434,3957,640143,20628,76684,99516,338
Asset impairment charges302,284(302,284)(5)--302,284(302,284)(5)--
Depreciation and amortization33,882(19,604)(6)10,953(2,796)(6)77,814(36,708)(6)32,999(8,982)(6)
Operating income(270,835)326,85223,44210,436(236,892)367,75851,99625,320
Interest expense(14,218)-(878)-(42,344)-(2,896)-
Other, net855(949)(7)9,474(9,162)(7)1,925(118)(7)10,520(10,009)(7)
Income before income taxes(284,198)325,90332,0381,274(277,311)367,64059,62015,311
Income tax expense8,191(18,325)(8)(6,688)323(8)6,934(28,884)(8)(12,644)(1,554)(8)
Net (loss) income$(276,007)$307,578$25,350$1,597$(270,377)$338,756$46,976$13,757
Diluted (loss) earnings per share$(6.04)$0.77$(5.83)$1.42
(1) Expense related to plant closure/relocation.
(2) Transaction, advisory fees, reorganization costs and product recall expenses.
(3) Amortization of step-up for purchase price adjustments on inventory.
(4) Restructuring charges related to severeance and disposal of software.
(5) Goodwill impairment.
(6) Amortization expense related to intangible assets and onetime deprecation adjustment.
(7) Pension settlement refund and foreign currency transaction gains.
(8) Tax impact of net income reconciling items.


QUANEX BUILDING PRODUCTS CORPORATION
SELECTED SEGMENT DATA
(In thousands)
(Unaudited)
This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments.
Hardware SolutionsExtruded SolutionsCustom SolutionsUnallocated Corp & OtherTotal
Three months ended July 31, 2025
Net sales$227,116$174,427$102,264$(8,534)$495,273
Cost of sales170,282116,59777,755(7,329)357,305
Gross Margin56,83457,83024,509(1,205)137,968
Gross Margin %25.0%33.2%24.0%27.9%
Selling, general and administrative(1)32,95420,74011,7085,86871,270
Restructuring charges1,14034261671,367
Depreciation and amortization16,9876,9894,7165,19033,882
Asset impairment charges163,19854,93484,152-302,284
Operating loss(157,445)(24,867)(76,093)(12,430)(270,835)
Depreciation and amortization16,9876,9894,7165,19033,882
Asset impairment charges163,19854,93484,152-302,284
EBITDA22,74037,05612,775(7,240)65,331
Expense related to plant relocation (Cost of sales)148---148
Transaction, advisory fees, reorganization costs, and product recall expenses715-502,6843,449
Restructuring charges related to severance1,14034261671,367
Adjusted EBITDA$24,743$37,090$12,851$(4,389)$70,295
Adjusted EBITDA Margin %10.9%21.3%12.6%14.2%
Three months ended July 31, 2024
Net sales$75,460$134,552$72,667$(2,334)$280,345
Cost of sales59,09292,79059,973(2,414)209,441
Gross Margin16,36841,76212,6948070,904
Gross Margin %21.7%31.0%17.5%25.3%
Selling, general and administrative(1)6,90615,6486,5597,39636,509
Depreciation and amortization1,2255,4604,2115710,953
Operating income (loss)8,23720,6541,924(7,373)23,442
Depreciation and amortization1,2255,4604,2115710,953
EBITDA9,46226,1146,135(7,316)34,395
Expense related to plant closure (Cost of sales)-1,507--1,507
Expense related to plant closure (SG&A)-125--125
Transaction and advisory fees---6,0086,008
Adjusted EBITDA$9,462$27,746$6,135$(1,308)$42,035
Adjusted EBITDA Margin %12.5%20.6%8.4%15.0%
Nine months ended July 31, 2025
Net sales$614,791$478,024$284,809$(29,829)$1,347,795
Cost of sales466,600325,914219,755(26,140)986,129
Gross Margin148,191152,11065,054(3,689)361,666
Gross Margin %24.1%31.8%22.8%26.8%
Selling, general and administrative(1)98,57060,92134,15614,606208,253
Restructuring charges8,15534261,99210,207
Depreciation and amortization38,81822,06615,6931,23777,814
Asset impairment charges163,19854,93484,152-302,284
Operating (loss) income(160,550)14,155(68,973)(21,524)(236,892)
Depreciation and amortization38,81822,06615,6931,23777,814
Asset impairment charges163,19854,93484,152-302,284
EBITDA41,46691,15530,872(20,287)143,206
Expense related to plant relocation (Cost of sales)1,124---1,124
Expense related to plant relocation (SG&A)247---247
Amortization of step-up for purchase price adjustments on inventory.7,2761,428302-9,006
Transaction, advisory fees, reorganization costs, and product recall expenses1,397177506,5588,182
Restructuring charges related to severance and disposal of software8,15534261,99210,207
Adjusted EBITDA$59,665$92,794$31,250$(11,737)$171,972
Adjusted EBITDA Margin %9.7%19.4%11.0%12.8%
Nine months ended July 31, 2024
Net sales$204,127$379,860$208,201$(6,487)$785,701
Cost of sales165,952263,107174,365(6,297)597,127
Gross Margin38,175116,75333,836(190)188,574
Gross Margin %18.7%30.7%16.3%24.0%
Selling, general and administrative(1)18,70445,73319,45619,686103,579
Depreciation and amortization3,53116,61612,68516732,999
Operating income (loss)15,94054,4041,695(20,043)51,996
Depreciation and amortization3,53116,61612,68516732,999
EBITDA19,47171,02014,380(19,876)84,995
Expense related to plant closure (Cost of sales)-2,138--2,138
Expense related to plant closure (SG&A)-1,103--1,103
Transaction and advisory fees---13,09713,097
Adjusted EBITDA$19,471$74,261$14,380$(6,779)$101,333
Adjusted EBITDA Margin %9.5%19.5%6.9%12.9%
(1) Includes stock-based compensation expense for the three and nine months ended July 31, 2025, respectively of $1.8 million and $3.6 million, and $1.3 million and $5.3 million for the comparable prior year periods.


QUANEX BUILDING PRODUCTS CORPORATION
SELECTED SEGMENT DATA RECONCILIATION
(In thousands)
(Unaudited)
This table reconciles our segment presentation, as previously reported in Exhibit 99.1 to our Current Report Form 8-K dated August 12, 2024 for the three and nine months ended July 31, 2024, to the current presentation.
NA FenestrationEU FenestrationNA Cabinet ComponentsUnallocated Corp & OtherTotal
Three months ended July 31, 2024
Net sales$170,258$59,617$51,448$(978)$280,345
Cost of sales130,30136,93042,911(701)209,441
Gross Margin39,95722,6878,537(277)70,904
Gross Margin %23.5%38.1%16.6%25.3%
Selling, general and administrative16,9187,3905,1627,03936,509
Depreciation and amortization5,1942,6093,0935710,953
Operating income (loss)17,84512,688282(7,373)23,442
Depreciation and amortization5,1942,6093,0935710,953
EBITDA23,03915,2973,375(7,316)34,395
Expense related to plant closure (Cost of sales)1,507---1,507
Expense related to plant closure (SG&A)125---125
Transaction and advisory fees---6,0086,008
Adjusted EBITDA$24,671$15,297$3,375$(1,308)$42,035
Adjusted EBITDA Margin %14.5%25.7%6.6%15.0%
Hardware Solutions(1)Extruded Solutions(2)Custom Solutions(3)Unallocated Corp & OtherTotal
Three months ended July 31, 2024
Net sales$75,460$134,552$72,667$(2,334)$280,345
Cost of sales59,09292,79059,973(2,414)209,441
Gross Margin16,36841,76212,6948070,904
Gross Margin %21.7%31.0%17.5%25.3%
Selling, general and administrative6,90615,6486,5597,39636,509
Depreciation and amortization1,2255,4604,2115710,953
Operating income8,23720,6541,924(7,373)23,442
Depreciation and amortization1,2255,4604,2115710,953
EBITDA9,46226,1146,135(7,316)34,395
Expense related to plant closure (Cost of sales)-1,507--1,507
Expense related to plant closure (SG&A)-125--125
Transaction and advisory fees---6,0086,008
Adjusted EBITDA$9,462$27,746$6,135$(1,308)$42,035
Adjusted EBITDA Margin %12.5%20.6%8.4%15.0%
NA FenestrationEU FenestrationNA Cabinet ComponentsUnallocated Corp & OtherTotal
Nine months ended July 31, 2024
Net sales$478,027$165,637$145,663$(3,626)$785,701
Cost of sales370,930104,327124,278(2,408)597,127
Gross Margin107,09761,31021,385(1,218)188,574
Gross Margin %22.4%37.0%14.7%24.0%
Selling, general and administrative46,55823,00815,35418,659103,579
Depreciation and amortization15,8877,7059,24016732,999
Operating income (loss)44,65230,597(3,209)(20,044)51,996
Depreciation and amortization15,8877,7059,24016732,999
EBITDA60,53938,3026,031(19,877)84,995
Expense related to plant closure (Cost of sales)2,138---2,138
Expense related to plant closure (SG&A)1,103---1,103
Transaction and advisory fees---13,09713,097
Adjusted EBITDA$63,780$38,302$6,031$(6,780)$101,333
Adjusted EBITDA Margin %13.3%23.1%4.1%12.9%
Hardware Solutions(1)Extruded Solutions(2)Custom Solutions(3)Unallocated Corp & OtherTotal
Nine months ended July 31, 2024
Net sales$204,127$379,860$208,201$(6,487)$785,701
Cost of sales165,952263,107174,365(6,297)597,127
Gross Margin38,175116,75333,836(190)188,574
Gross Margin %18.7%30.7%16.3%24.0%
Selling, general and administrative18,70445,73319,45619,686103,579
Depreciation and amortization3,53116,61612,68516732,999
Operating income (loss)15,94054,4041,695(20,043)51,996
Depreciation and amortization3,53116,61612,68516732,999
EBITDA19,47171,02014,380(19,876)84,995
Loss on damage to manufacturing facilities (Cost of sales)-2,138--2,138
Loss on damage to manufacturing facilities (SG&A)-1,103--1,103
Transaction and advisory fees---13,09713,097
Adjusted EBITDA$19,471$74,261$14,380$(6,779)$101,333
Adjusted EBITDA Margin %9.5%19.5%6.9%12.9%
(1) The Hardware Solutions segment contains a portion of the previously reported NA Fenestration segment.
(2) The Extruded Solutions segment contains a portion of the NA Fenestration segment and the EU Fenestration segment.
(3) The Custom Solutions segment contains a portion of the NA Fenestration segment and the NA Cabinet Components segment.


QUANEX BUILDING PRODUCTS CORPORATION
SALES ANALYSIS
(In thousands)
(Unaudited)
Three Months Ended July 31,Nine Months Ended July 31,
2025202420252024
Hardware Solutions:
Window and door hardware$150,307$-$411,522$-
Screens76,80975,460203,269204,127
$227,116$75,460$614,791$204,127
Extruded Solutions:(1)
Window profiles$68,165$67,802$182,273$193,758
Seals and gaskets29,86516,51384,91542,714
Spacers54,74337,868146,544104,047
Solar5,2505,19817,83516,074
Flashing Tape3,0384,9056,75113,512
Window and door hardware10,044-29,694-
Other3,3222,26610,0129,755
$174,427$134,552$478,024$379,860
Custom Solutions:
Wood solutions$53,409$51,448$148,456$145,663
Access solutions27,370-74,158-
Mixing solutions21,48521,21962,19562,538
$102,264$72,667$284,809$208,201
Unallocated Corporate & Other:
Eliminations$(8,534)$(2,334)$(29,829)$(6,487)
$(8,534)$(2,334)$(29,829)$(6,487)
Net Sales$495,273$280,345$1,347,795$785,701
(1) Reflects an increase of $2.6 million and $2.9 million in revenue associated with foreign currency exchange rate impacts for the three and nine months ended July 31, 2025, respectively.

FAQ

What were Quanex's (NX) Q3 2025 earnings results?

Quanex reported Q3 2025 net sales of $495.3 million, a 76.7% increase year-over-year, but posted a net loss of $276.0 million primarily due to a $302.3 million non-cash goodwill impairment charge.

How much debt did Quanex (NX) repay in Q3 2025?

Quanex repaid $51.25 million of debt in Q3 2025, reducing its leverage ratio to 2.6x.

What is Quanex's (NX) full-year 2025 guidance?

Quanex expects to generate net sales of approximately $1.82 billion and Adjusted EBITDA of approximately $235 million for fiscal 2025.

What cost synergies does Quanex expect from the Tyman acquisition?

Quanex expects to realize approximately $45 million in cost synergies over time, which is above their initial projection of $30 million.

How much cash does Quanex (NX) have available as of Q3 2025?

As of July 31, 2025, Quanex had $66.3 million in cash and total liquidity of $337.7 million, including availability under its credit facility.

What is Quanex's current share repurchase program status?

Quanex repurchased 100,000 shares for approximately $2.1 million in Q3 2025, with $33.6 million remaining under the existing $75 million authorization.
Quanex Build

NYSE:NX

NX Rankings

NX Latest News

NX Latest SEC Filings

NX Stock Data

923.60M
45.50M
1.03%
102.61%
3.57%
Building Products & Equipment
Rolling Drawing & Extruding of Nonferrous Metals
United States
HOUSTON